A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Asimadoline (Primary)
- Indications Pruritus
- Focus Proof of concept; Therapeutic Use
- Sponsors Tioga Pharmaceuticals
- 16 Mar 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by Clinicaltrials.gov.
- 16 Mar 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 15 Jun 2015 New trial record